SOFIA DIANA MERAJVER
Medical Practice in Ann Arbor, MI

License number
Michigan 4301053252
Issued Date
Aug 11, 1989
Expiration Date
Jan 31, 2018
Category
Medicine
Type
Medical Doctor
Address
Address
Ann Arbor, MI 48109

Personal information

See more information about SOFIA DIANA MERAJVER at radaris.com
Name
Address
Phone
Sofia Merajver
715 Oakdale Rd, Ann Arbor, MI 48105
Sofia Merajver
2755 Daleview Dr, Ann Arbor, MI 48105

Professional information

See more information about SOFIA DIANA MERAJVER at trustoria.com
Sofia D Merajver Photo 1
Dr. Sofia D Merajver, Ann Arbor MI - MD (Doctor of Medicine)

Dr. Sofia D Merajver, Ann Arbor MI - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Address:
1500 E Medical Center Dr SUITE 7217, Ann Arbor 48109
(734) 764-2248 (Phone), (734) 615-2719 (Fax)
Certifications:
Internal Medicine, 1991, Medical Oncology, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1500 E Medical Center Dr SUITE 7217, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
University of Mi Med Sch
Graduated: 1987
University Of Michigan Hospitals


Sofia D Merajver Photo 2
Sofia D Merajver, Ann Arbor MI

Sofia D Merajver, Ann Arbor MI

Specialties:
Oncologist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
University of Michigan, Medical School - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)


Sofia Merajver Photo 3
Methods And Compositions For The Prevention Or Treatment Of Cancer

Methods And Compositions For The Prevention Or Treatment Of Cancer

US Patent:
6703050, Mar 9, 2004
Filed:
Sep 3, 1999
Appl. No.:
09/389435
Inventors:
George J. Brewer - Ann Arbor MI
Sofia D. Merajver - Ann Arbor MI
Dimitri Coucouvanis - Ann Arbor MI
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 3334
US Classification:
424641, 424646, 514 53, 514502
Abstract:
Provided are agents that can bind to copper, and form a tripartite complex with protein, and the use of these agents in the prevention and treatment of diseases with a vascular component, such as solid tumors. Compositions and methods for combination therapy of these diseases, including cancer, as well as therapeutic kits, are also provided.


Sofia Merajver Photo 4
Tetrapropylammonium Tetrathiomolybdate And Related Compounds For Anti-Angiogenic Therapies

Tetrapropylammonium Tetrathiomolybdate And Related Compounds For Anti-Angiogenic Therapies

US Patent:
7888389, Feb 15, 2011
Filed:
Jul 23, 2003
Appl. No.:
10/625839
Inventors:
George J. Brewer - Ann Arbor MI, US
Sofia D. Merajver - Ann Arbor MI, US
Dimitri Coucouvanis - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 31/14, A61K 31/28
US Classification:
514492, 514642
Abstract:
Disclosed are copper-binding compounds with improved properties and methods of using such compounds in the prevention and treatment of angiogenic diseases, such as cancer. Advantages of the invention include the enhanced stability of the compounds, which is achieved without reduction in efficacy. Pharmaceutical compositions, therapeutic kits and combination treatment methods and uses are also provided.


Sofia Merajver Photo 5
Methods And Compositions For The Treatment Of Angiogenic Diseases

Methods And Compositions For The Treatment Of Angiogenic Diseases

US Patent:
7438931, Oct 21, 2008
Filed:
Mar 9, 2004
Appl. No.:
10/796782
Inventors:
George J. Brewer - Ann Arbor MI, US
Sofia D. Merajver - Ann Arbor MI, US
Dimitri Coucouvanis - Ann Arbor MI, US
Assignee:
The Regents of The University of Michigan - Ann Arbor MI
International Classification:
A61K 33/34, A61K 33/30
US Classification:
424641, 424646, 514502
Abstract:
Provided are agents that can bind to copper, and form a tripartite complex with protein, and the use of these agents in the prevention and treatment of diseases with a vascular component, such as solid tumors. Compositions and methods for combination therapy of these diseases, including cancer, as well as therapeutic kits, are also provided.